The invention provides novel .beta..sub.2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with .beta..sub.2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.

 
Web www.patentalert.com

< Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition

> Systems, methods, and compositions for achieving closure of vascular puncture sites
~ 00449